Inbrija™ (levodopa) – New drug approval
December 21, 2018 - Acorda Therapeutics announced the FDA approval of Inbrija (levodopa) inhalation powder, for the intermittent treatment of OFF episodes in people with Parkinson’s disease treated with carbidopa/levodopa.
Download PDF
